SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022738
Filing Date
2017-11-08
Accepted
2017-11-08 16:11:25
Documents
55
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-10q_20170930.htm 10-Q 2719448
2 EX-4.6 fgen-ex46_97.htm EX-4.6 704160
3 EX-10.9 fgen-ex109_208.htm EX-10.9 570284
4 EX-31.1 fgen-ex311_6.htm EX-31.1 8274
5 EX-31.2 fgen-ex312_8.htm EX-31.2 8268
6 EX-32.1 fgen-ex321_7.htm EX-32.1 7490
7 GRAPHIC g201711081944091371063.jpg GRAPHIC 14457
8 GRAPHIC g201711081943459531634.jpg GRAPHIC 72181
  Complete submission text file 0001564590-17-022738.txt   8928549

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT fgen-20170930.xml EX-101.INS 1720911
10 XBRL TAXONOMY EXTENSION SCHEMA fgen-20170930.xsd EX-101.SCH 36359
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fgen-20170930_cal.xml EX-101.CAL 50935
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fgen-20170930_def.xml EX-101.DEF 119023
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20170930_lab.xml EX-101.LAB 282928
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20170930_pre.xml EX-101.PRE 228566
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 171186719
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences